| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $183.83M | $148.08M | $118.66M | $106.78M | $87.57M |
| SG&A | $51.18M | $46.45M | $38.20M | $36.12M | $33.81M |
| Operating Income | -$182.02M | -$38.62M | -$101.72M | $29.95M | -$86.29M |
| Interest Expense | $36.67M | $1.32M | -$7.04M | $8.28M | $1.73M |
| Tax Expense | -$1.99M | $6.13M | $0.00 | $4.52M | $0.00 |
| Net Income | -$196.45M | $15.22M | -$96.99M | $37.51M | -$93.33M |
| EPS (basic) | -1.6100 | 0.1400 | -1.2000 | 0.5600 | – |
| EPS (diluted) | -1.6100 | 0.1400 | -1.2000 | 0.5500 | – |
| Shares (diluted) | $122.35M | $106.80M | $80.55M | $68.82M | – |